2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina... Read more
JOIN OUR MANAGEMENT COMMUNITY
Medicus Announces Diagnostic-Data Mobility Initiative
Medicus , a Vienna-based digital health company, is proud to announce... Read more
Driving regional anaesthesia forward with point-of-care ultrasound
Point-of-care ultrasound is playing an important role in the anaesthesiology... Read more
Sectra to provide vendor-neutral platform for medical imaging AI project in the UK
International medical imaging IT and cybersecurity company Sectra... Read more
Masimo announces FDA clearance of the rainbow acoustic monitoring® RAS-45 sensor
Masimo announced today FDA clearance of RAS-45, an acoustic respiration... Read more
SCHILLER launches the ECG device CARDIOVIT AT-102 G2
SCHILLER’s latest ECG device CARDIOVIT AT-102 G2 has been launched.... Read more
Farewell: Stefan Burkart leaves Entscheiderfabrik
The last day of the fair at this year's Medica was also the last... Read more
Ascom Holding AG: Ascom appoints Ljubisav Matejevic to lead the Strategic Alliances business
Ascom invests further into its strategic partners business by appointing... Read more
HANJ Recognizes CSL CEO Paul Perreault as “Humanitarian Man of the Year”
HANJ President David Lechner presented the award to Perreault at the... Read more
Geraldine McGinty to Receive Thorwarth Award for Radiology Leadership
The American College of Radiology selected Geraldine McGinty ,... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY